Previous studies have shown that ACTA2 is one of the pivotal genes closely associated with the immune response in muscle invasive bladder cancer (MIBC) (47), which not only reveals the important role of ACTA2 in the development of MIBC but also provides a new research direction for an in-depth understanding of the mechanism of tumor immune microenvironment regulation. This evidence concerns the gene ACTA2 and neoplasm.